Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs

John C S Breitner, Kathleen A. Welsh, Michael J. Helms, Perry C. Gaskell, Barbara A. Gau, Allen D. Roses, Margaret A Pericak-Vance, Ann M. Saunders

Research output: Contribution to journalArticle

375 Citations (Scopus)

Abstract

Factors that modify onset of Alzheimer's disease (AD) may be revealed by comparing environmental exposures in affected and unaffected members of discordant twin pairs or sibships. Among siblings at high risk of AD, sustained use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with delayed onset and reduced risk of AD. After adjustment for use of NSAIDs, there was minimal effect on onset with reported history of any of three common illnesses (arthritis, diabetes, or acid-peptic disease). However, independent of exposure to NSAIDs, onset was unexpectedly delayed in those reporting extended use of histamine H2 blocking drugs. Randomized clinical trials will be needed to affirm the utility of these drugs for prevention, but the present findings may have implications for pathogenesis: because NSAIDs block the calcium-dependent postsynaptic cascade that induces excitotoxic cell death in NMDA-reactive neurons, and because histamine potentiates such events, excitotoxicity may deserve additional investigation in AD.

Original languageEnglish
Pages (from-to)523-530
Number of pages8
JournalNeurobiology of Aging
Volume16
Issue number4
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Histamine
Alzheimer Disease
Anti-Inflammatory Agents
Pharmaceutical Preparations
Environmental Exposure
N-Methylaspartate
Arthritis
Digestion
Cell Death
Randomized Controlled Trials
Calcium
Neurons
Acids

Keywords

  • Alzheimer's disease
  • Cyclooxygenase
  • Excitotoxicity
  • Histamine
  • Histamine H2 blocking drugs
  • Inflammation
  • NMDA glutamate receptors
  • Nonsteroidal anti-inflammatory drugs
  • Onset

ASJC Scopus subject areas

  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology
  • Clinical Neurology
  • Neuroscience(all)
  • Biological Psychiatry
  • Developmental Neuroscience
  • Neurology
  • Psychology(all)

Cite this

Breitner, J. C. S., Welsh, K. A., Helms, M. J., Gaskell, P. C., Gau, B. A., Roses, A. D., ... Saunders, A. M. (1995). Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiology of Aging, 16(4), 523-530. https://doi.org/10.1016/0197-4580(95)00049-K

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. / Breitner, John C S; Welsh, Kathleen A.; Helms, Michael J.; Gaskell, Perry C.; Gau, Barbara A.; Roses, Allen D.; Pericak-Vance, Margaret A; Saunders, Ann M.

In: Neurobiology of Aging, Vol. 16, No. 4, 01.01.1995, p. 523-530.

Research output: Contribution to journalArticle

Breitner, John C S ; Welsh, Kathleen A. ; Helms, Michael J. ; Gaskell, Perry C. ; Gau, Barbara A. ; Roses, Allen D. ; Pericak-Vance, Margaret A ; Saunders, Ann M. / Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. In: Neurobiology of Aging. 1995 ; Vol. 16, No. 4. pp. 523-530.
@article{0e33af531d6f4fd9917da365a6e3462e,
title = "Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs",
abstract = "Factors that modify onset of Alzheimer's disease (AD) may be revealed by comparing environmental exposures in affected and unaffected members of discordant twin pairs or sibships. Among siblings at high risk of AD, sustained use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with delayed onset and reduced risk of AD. After adjustment for use of NSAIDs, there was minimal effect on onset with reported history of any of three common illnesses (arthritis, diabetes, or acid-peptic disease). However, independent of exposure to NSAIDs, onset was unexpectedly delayed in those reporting extended use of histamine H2 blocking drugs. Randomized clinical trials will be needed to affirm the utility of these drugs for prevention, but the present findings may have implications for pathogenesis: because NSAIDs block the calcium-dependent postsynaptic cascade that induces excitotoxic cell death in NMDA-reactive neurons, and because histamine potentiates such events, excitotoxicity may deserve additional investigation in AD.",
keywords = "Alzheimer's disease, Cyclooxygenase, Excitotoxicity, Histamine, Histamine H2 blocking drugs, Inflammation, NMDA glutamate receptors, Nonsteroidal anti-inflammatory drugs, Onset",
author = "Breitner, {John C S} and Welsh, {Kathleen A.} and Helms, {Michael J.} and Gaskell, {Perry C.} and Gau, {Barbara A.} and Roses, {Allen D.} and Pericak-Vance, {Margaret A} and Saunders, {Ann M.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/0197-4580(95)00049-K",
language = "English",
volume = "16",
pages = "523--530",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs

AU - Breitner, John C S

AU - Welsh, Kathleen A.

AU - Helms, Michael J.

AU - Gaskell, Perry C.

AU - Gau, Barbara A.

AU - Roses, Allen D.

AU - Pericak-Vance, Margaret A

AU - Saunders, Ann M.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Factors that modify onset of Alzheimer's disease (AD) may be revealed by comparing environmental exposures in affected and unaffected members of discordant twin pairs or sibships. Among siblings at high risk of AD, sustained use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with delayed onset and reduced risk of AD. After adjustment for use of NSAIDs, there was minimal effect on onset with reported history of any of three common illnesses (arthritis, diabetes, or acid-peptic disease). However, independent of exposure to NSAIDs, onset was unexpectedly delayed in those reporting extended use of histamine H2 blocking drugs. Randomized clinical trials will be needed to affirm the utility of these drugs for prevention, but the present findings may have implications for pathogenesis: because NSAIDs block the calcium-dependent postsynaptic cascade that induces excitotoxic cell death in NMDA-reactive neurons, and because histamine potentiates such events, excitotoxicity may deserve additional investigation in AD.

AB - Factors that modify onset of Alzheimer's disease (AD) may be revealed by comparing environmental exposures in affected and unaffected members of discordant twin pairs or sibships. Among siblings at high risk of AD, sustained use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with delayed onset and reduced risk of AD. After adjustment for use of NSAIDs, there was minimal effect on onset with reported history of any of three common illnesses (arthritis, diabetes, or acid-peptic disease). However, independent of exposure to NSAIDs, onset was unexpectedly delayed in those reporting extended use of histamine H2 blocking drugs. Randomized clinical trials will be needed to affirm the utility of these drugs for prevention, but the present findings may have implications for pathogenesis: because NSAIDs block the calcium-dependent postsynaptic cascade that induces excitotoxic cell death in NMDA-reactive neurons, and because histamine potentiates such events, excitotoxicity may deserve additional investigation in AD.

KW - Alzheimer's disease

KW - Cyclooxygenase

KW - Excitotoxicity

KW - Histamine

KW - Histamine H2 blocking drugs

KW - Inflammation

KW - NMDA glutamate receptors

KW - Nonsteroidal anti-inflammatory drugs

KW - Onset

UR - http://www.scopus.com/inward/record.url?scp=0029160270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029160270&partnerID=8YFLogxK

U2 - 10.1016/0197-4580(95)00049-K

DO - 10.1016/0197-4580(95)00049-K

M3 - Article

VL - 16

SP - 523

EP - 530

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 4

ER -